Obesity and subsequent complications are increasing in frequency worldwide. The accumulation of adipose tissue is associated with increased inflammation, and it has been proposed that modification of proinflammatory responses could alter adipose tissue composition. A study in this issue of JCI Insight demonstrates that mice lacking the proinflammatory signaling molecule TAK1 are protected from obesity and insulin resistance induced by a high fat diet. A team led by Antonia Sassmann-Schweda of the Max-Planck-Institute for Heart and Lung Research and colleagues generated mice lacking TAK1 specifically in adipocytes. Compared to control animals, TAK1-deficient mice had reduced numbers of adipocytes and exhibited increased energy expenditure. Moreover, removal of TAK1 from mice that had previously been fed a high fat diet prevented additional weight gain and improved glucose tolerance. The results of this study suggest that TAK1 should be further explored as a target for obesity treatment.
###
TITLE:
Increased apoptosis and browning of TAK1-deficient adipocytes protects against obesity
AUTHOR CONTACT:
Antonia Sassmann-Schweda
Max-Planck-Institute for Heart and Lung Research
Email: Antonia.Sassmann@mpi-bn.mpg.de
View this article at: http://insight.jci.org/articles/view/81175?key=8e6ccec1779970bd3e1b
JCI Insight is the newest publication from the American Society of Clinical Investigation, a nonprofit honor organization of physician-scientists. JCI Insight is dedicated to publishing a range of translational biomedical research with an emphasis on rigorous experimental methods and data reporting. All articles published in JCI Insight are freely available at the time of publication. For more information about JCI Insight and all of the latest articles go to http://www.insight.jci.org .
JCI Insight